 August 31, 2007
|
Zero Infections in Large Sperm Washing Study
Sperm “washing” appears to be a safe and effective option for couples wishing to have a child where the potential father is HIV positive, according to a European study reported in the September 2007 issue of AIDS.
|
|
|
August 29, 2007
|
Nukes, Not PIs, Linked to Diabetes Risk
Debunking the long-standing notion that protease inhibitors are a major culprit in the risk of developing diabetes, new data suggest that nucleoside reverse transcriptase inhibitors (NRTI) use may be the cause.
|
|
|
Memantine May Help Prevent, Not Treat, Dementia
Memantine, long considered to be a potential treatment for HIV-linked cognitive problems and other neurological complications, has been found not to be an effective treatment for AIDS-related dementia.
|
|
|
August 27, 2007
|
Marijuana or Marinol? Both Show Benefits
Marijuana and Marinol produce substantial and comparable increases in food intake and weight gain, according to the first-ever study comparing the smoked leaf with the manufactured capsules.
|
|
|
| August 24, 2007
|
August 22, 2007
|
Put All Your Pills in One Basket
A study confirms that pillbox organizers greatly improve adherence to HIV drug treatment and increase the chances of lowering viral load.
|
|
|
Fat Buildup Increases Insulin Resistance Risk
A buildup of subcutaneous adipose tissue (SAT) of the upper trunk—fat below the skin in the chest and back (“buffalo hump”)—is associated with insulin resistance in HIV-positive patients.
|
|
|
August 21, 2007
|
New Blood Test for PCP Holds Promise
A blood test may make it easier for doctors to diagnose Pneumocystis pneumonia (PCP) in people with compromised immune systems, according to a small Boston-based study.
|
|
|
August 20, 2007
|
Scientists Say Internet Gives AIDS Denialists New Life
Scientists were for the most part able to ignore HIV denialists—those who say that HIV is not the cause of AIDS—until the internet came along, according to a new article published in the Public Library of Science online.
|
|
|
August 17, 2007
|
Kidney Problems Require Careful NRTI Dosing
One-third of HIV-positive patients with kidney problems at an Alabama clinic received incorrect NRTI prescriptions, suggesting a need for more vigilant dosing precautions.
|
|
|
August 16, 2007
|
Cost Shouldn’t Be Obstacle to Lipo Treatment
Given that facial lipoatrophy and other stigmatizing body-shape changes associated with lipodystrophy are caused in part by treatments for HIV, doesn’t the healthcare system have an ethical responsibility to provide and pay for restorative therapies?
|
|
|
| August 15, 2007
|
August 14, 2007
|
Good Treatment Results for Over 50s
Older HIV-positive people respond well to HIV treatment, but are more often diagnosed later and switch their drugs sooner, compared to younger patients.
|
|
|
August 13, 2007
|
Infant Dies of Kaletra Overdose, Prompts Warning
An HIV-positive infant has died after an accidental Kaletra (lopinavir plus ritonavir) overdose, prompting Abbott Laboratories to issue a letter reminding healthcare professionals about the correct dose for children.
|
|
|
August 10, 2007
|
High CD4s No Guarantee against AIDS and Death
New data, finding an an increased risk of AIDS-related diseases or death among HIV-positive people with relatively high CD4 cell counts, speak to the growing need for early treatment studies.
|
|
|
August 09, 2007
|
HPV Vaccination For All Positive Gay Men?
All HIV-positive gay men should receive Gardasil, the vaccine that prevents cancerous human papillomavirus (HPV) types 16 and 18, said researchers at the IAS Conference in Sydney.
|
|
|
| August 08, 2007
|
August 07, 2007
|
Women Do Better on Tipranavir/Ritonavir
Trial results presented at the International AIDS Society Conference in Sydney, Australia indicate that a combination of Aptivus (tipranavir) and Norvir (ritonavir) results in a better CD4 cell count response among treatment-experienced women than in it does among men.
|
|
|
| August 06, 2007
|
| August 02, 2007
|
August 01, 2007
|
Lexiva vs. Reyataz: Comparable Efficacy
Lexiva or Reyataz, both combined with Norvir, are similar in their effectiveness. A second study suggests that the dose of Norvir currently used to boost Lexiva levels in the bloodstream can be halved without compromising effectiveness.
|
|
|
|
